vimarsana.com

Latest Breaking News On - Viral vector technologies - Page 1 : vimarsana.com

Leadership 100 Conference Commemorates the 100th Anniversary of Greek Orthodox Archdiocese - Affiliates

The 31st Annual Leadership 100 Conference will convene February 10-13, 2022, at The Ritz-Carlton Naples in Naples, Florida. Argyris Vassiliou, Chairman of Leadership 100, announced that this year’s conference will be dedicated to the Centennial of the Greek Orthodox Archdiocese of America. Vassiliou stated, “We are honored to begin the Centennial celebrations with our Thursday Forum speakers who will reflect on the history and progress of our Archdiocese.” The 31st Annual Leadership 100 Conference will convene February 10-13, 2022, at The Ritz-Carlton Naples in Naples, Florida. Argyris Vassiliou, Chairman of Leadership 100, announced that this year’s.

REGEN-COV™ Antibody Cocktail Is Active Against SARS-CoV-2 Variants First Identified in the UK and South Africa

Columbia University researchers and Regeneron have independently confirmed findings; data included in bioRxiv paper and submitted for peer-reviewed publication Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that researchers in Dr. David Ho s Columbia University lab and Regeneron scientists have independently confirmed that REGEN-COV TM (casirivimab and imdevimab antibody cocktail) successfully neutralizes the circulating SARS-CoV-2 variants first identified in the UK (B.1.1.7) and South Africa (B.1.351). Columbia s findings were included in a paper posted to bioRxiv and submitted for peer-reviewed publication on the changing resistance of SARS-CoV-2 variants to antibody neutralization. Both teams of researchers assessed in vitro neutralization potency of numerous COVID-19 antibodies (including those that have received emergency authorization and those still in development) against various mutated strains of the virus. Although some antibody therapies were no l

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.